Sumitomo Mitsui Trust Holdings, Inc. Catalent, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 390,945 shares of CTLT stock, worth $23.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
390,945
Previous 423,957
7.79%
Holding current value
$23.4 Million
Previous $23.9 Million
8.15%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding CTLT
# of Institutions
489Shares Held
165MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$921 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$660 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$440 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$298 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.8B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...